Create an alert
to follow the executive moves at Fennec Pharma.
Click on an executive to view his biography >
Kymab and Sanofi have announced they will merge (posted on Jan 11, 2021).
PerkinElmer has announced the acquisition of Oxford Immunotec (posted on Jan 8, 2021).
Syneos Health has announced the acquisition of SynteractHCR (posted on Dec 18, 2020).
Fennec Announces Issuance of U.S. Patent for PEDMARK™ | Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences | Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Receives Complete Response Letter from the FDA for its New Drug Application for PEDMARK™ to Prevent Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic, Solid Tumors | Fennec Pharmaceuticals In
Fennec Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Business Update | Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Announces Amendment to Increase Existing Senior Debt Facility | Fennec Pharmaceuticals Inc.
Fennec Pharma on Wikipedia, Google News & Yahoo Finance
Fennec Pharma on LinkedIn, Twitter & YouTube
Fennec Pharma has 1,539 competitors including Biogen (United States (USA)), Agilyx (United States (USA)) and Eurofins (France).
Learn about your clients' org charts. Understand their industries and their competitors.
View the executives' biographies. Contact the executives through our email platform.
Select key words to follow your clients. Receive alerts when executive movements happen.
File your clients in folders. Add private notes. Download our data in Excel on your PC.